CHICAGO — In this Healio Video Perspective from the AAO meeting, Veeral S. Sheth, MD, MBA, FASRS, FACS, discusses the correlation of retinal thickness and visual outcomes based on post hoc data from the PALADIN study.
“We want to keep our patients drier for longer periods of time,” he said. “With Iluvien, we see that continuous delivery of medication that allows us to maintain these dry retinas for a long period of time, which translates to better vision outcomes in the end.”